Euronoxx Medical Group

Founded in London in 2022, Euronoxx Medical Group is redefining the future of healthcare delivery as a global distributor of advanced medical technologies. With a mission to challenge conventions, we are committed to driving innovation, precision, and quality across every solution we provide.

At the forefront of our portfolio is the Koning Vera 3D Breast CT, a breakthrough in diagnostic imaging that delivers true volumetric scans in just seven seconds, without breast compression. This technology eliminates traditional barriers in breast cancer detection, combining unparalleled patient comfort with next-generation diagnostic accuracy. We also deliver Allengers’ advanced imaging systems, including digital mammography solutions engineered for ultra-low radiation doses and unmatched image clarity, ensuring clinicians gain sharper insights with maximum patient safety. Furthermore, we represent Time Medical’s NEONA, the world’s first neonatal MRI system, designed to deliver silent, space-efficient imaging for neonatal and pediatric care, especially in environments where conventional MRI is impractical.

As an approved NHS ethical recruiter, Euronoxx provides not just access to transformative technologies but also end-to-end integration, 24/7 specialist support, and med-tech consulting, empowering healthcare providers to scale impact with precision. Our philosophy is simple Technology should serve both the clinician and the patient. At Euronoxx, we curate imaging systems that push boundaries in their own right, whether it's redefining breast imaging through innovation that prioritizes patient comfort, delivering diagnostic precision with minimal radiation exposure, or providing compact yet powerful platforms that bring advanced care to more settings. Each solution in our portfolio is selected not merely for its specifications, but for its ability to remove obstacles, strengthen clinical confidence, and place the human experience at the center of care.